<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Tumors of female reproductive system</journal-id><journal-title-group><journal-title xml:lang="en">Tumors of female reproductive system</journal-title><trans-title-group xml:lang="ru"><trans-title>Опухоли женской репродуктивной системы</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1994-4098</issn><issn publication-format="electronic">1999-8627</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">352</article-id><article-id pub-id-type="doi">10.17650/1994-4098-2008-0-2-55-59</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>GYNECOLOGY. TOPICAL SUBJECT</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ГИНЕКОЛОГИЯ. АКТУАЛЬНАЯ ТЕМА</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">CLINICAL CHARACTERISTICS OF OVARIAN CLEAR CELL CANCER</article-title><trans-title-group xml:lang="ru"><trans-title>КЛИНИЧЕСКАЯ ХАРАКТЕРИСТИКА СВЕТЛОКЛЕТОЧНОГО РАКА ЯИЧНИКОВ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Akhmedova</surname><given-names>M. D.</given-names></name><name xml:lang="ru"><surname>Ахмедова</surname><given-names>М. Д.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Barinov</surname><given-names>V. V.</given-names></name><name xml:lang="ru"><surname>Баринов</surname><given-names>В. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shabanov</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Шабанов</surname><given-names>М. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zhordania</surname><given-names>K. I.</given-names></name><name xml:lang="ru"><surname>Жорданиа</surname><given-names>К. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Bokina</surname><given-names>L. I.</given-names></name><name xml:lang="ru"><surname>Бокина</surname><given-names>Л. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Peskova</surname><given-names>V. I.</given-names></name><name xml:lang="ru"><surname>Пескова</surname><given-names>В. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Panichenko</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Паниченко</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin Cancer Research Center of Russian Academy of Medical Sciences, Moscow</institution></aff><aff><institution xml:lang="ru">ГУ РОНЦ им. Н.Н. Блохина РАМН, Москва</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ГУ РОНЦ им. Н.Н. Блохина РАМН, Москва</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2008-05-16" publication-format="electronic"><day>16</day><month>05</month><year>2008</year></pub-date><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>55</fpage><lpage>59</lpage><history><date date-type="received" iso-8601-date="2014-09-16"><day>16</day><month>09</month><year>2014</year></date><date date-type="accepted" iso-8601-date="2014-09-16"><day>16</day><month>09</month><year>2014</year></date></history><permissions><copyright-year>2008</copyright-year><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://ojrs.abvpress.ru/ojrs/article/view/352">https://ojrs.abvpress.ru/ojrs/article/view/352</self-uri><abstract xml:lang="en"><p>The research has enrolled 96 patients with rare ovarian clear cell cancer treated at N.N. Blokhin Russian Cancer Research Center from 1978 to 2000. A necessity to divide patients into two groups has emerged after histopathological slide review. The first group included 71 patients with ovarian clear cell carcinoma (OCCC). Twenty five patients with mixed malignant epithelial ovarian tumor (MMEOT) with mandatory presence of clear cell component were included into the second group. Clinical par- ticularities of clear cell ovarian cancer were studied. We performed a comparative study of clinical course of OCCC and MMEOT. Our data suggest that clear cell ovarian cancer has a number of typical clinical and biological particularities both in OCCC and MMEOT.</p></abstract><trans-abstract xml:lang="ru"><p>КЛИНИЧЕСКАЯ ХАРАКТЕРИСТИКА СВЕТЛОКЛЕТОЧНОГО РАКА ЯИЧНИКОВ</p></trans-abstract><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Жорданиа К.И. Злокачественные новообразования яичников. Энциклопедия клинической онкологиии. М.; 2004.</mixed-citation><mixed-citation xml:lang="ru">Жорданиа К.И. Злокачественные новообразования яичников. Энциклопедия клинической онкологиии. М.; 2004.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Трапезников Н.Н., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ (состояние онкологической помощи, заболеваемость и смертность). М.; 2001. с. 95—6.</mixed-citation><mixed-citation xml:lang="ru">Трапезников Н.Н., Аксель Е.М. Статистика злокачественных новообразований в России и странах СНГ (состояние онкологической помощи, заболеваемость и смертность). М.; 2001. с. 95—6.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Fine G., Clarke H., Horn R. Mesonephroma of the ovary. Cancer 1973;31:398—410.</mixed-citation><mixed-citation xml:lang="ru">Fine G., Clarke H., Horn R. Mesonephroma of the ovary. Cancer 1973;31:398—410.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Kennedy A.W., Biscotti C.V., Hart W.R., Tuason L.J. Histologic corre- lates of progression-free interval and sur- vival in ovarian clear cell adenocarcinoma. Gynecol Oncol 1993;50(3): 334—8.</mixed-citation><mixed-citation xml:lang="ru">Kennedy A.W., Biscotti C.V., Hart W.R., Tuason L.J. Histologic corre- lates of progression-free interval and sur- vival in ovarian clear cell adenocarcinoma. Gynecol Oncol 1993;50(3): 334—8.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Pettersson F. Annual report of the results of treatment in gynecological cancer. Stockholm, International Federation of Gynecology and Obstetrics; 1991.</mixed-citation><mixed-citation xml:lang="ru">Pettersson F. Annual report of the results of treatment in gynecological cancer. Stockholm, International Federation of Gynecology and Obstetrics; 1991.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Fukunaga M., Nomura K., Ishikawa E., Ushigome S. Ovarian atypi- cal endometriosis: its close association with malignant epithelial tumours. Histopathology 1998;32(2):182.</mixed-citation><mixed-citation xml:lang="ru">Fukunaga M., Nomura K., Ishikawa E., Ushigome S. Ovarian atypi- cal endometriosis: its close association with malignant epithelial tumours. Histopathology 1998;32(2):182.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Obrien M.E., Schofield J.B., Tan S. et al. Clear cell epithelial ovarian carci- noma (mesonephroid) bad prognosis only in early stages. Gynecol Oncol 1993;49:250—4.</mixed-citation><mixed-citation xml:lang="ru">Obrien M.E., Schofield J.B., Tan S. et al. Clear cell epithelial ovarian carci- noma (mesonephroid) bad prognosis only in early stages. Gynecol Oncol 1993;49:250—4.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Parther S., Quinn M.A. Clear cell cancer of the ovary-is it chemosensitive. Dyagn Cytopathol 2005;32(6):336—40.</mixed-citation><mixed-citation xml:lang="ru">Parther S., Quinn M.A. Clear cell cancer of the ovary-is it chemosensitive. Dyagn Cytopathol 2005;32(6):336—40.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Sugiyama T., Kamura T., Kigawa J. et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histo- logic type with poor prognosis and resist- ance to platinum-based chemotherapy. Cancer 2000;88:2584—9.</mixed-citation><mixed-citation xml:lang="ru">Sugiyama T., Kamura T., Kigawa J. et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histo- logic type with poor prognosis and resist- ance to platinum-based chemotherapy. Cancer 2000;88:2584—9.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Skirnisdottir I., Seidal T., Karlsson M.G. et al. Clinical and biolog- ical characteristics of clear cell carcino- mas of the ovary in FIGO stages I-II. Int J Oncol 2005;26:177—83.</mixed-citation><mixed-citation xml:lang="ru">Skirnisdottir I., Seidal T., Karlsson M.G. et al. Clinical and biolog- ical characteristics of clear cell carcino- mas of the ovary in FIGO stages I-II. Int J Oncol 2005;26:177—83.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Yoonessi M., Weldon D., Satchidand S.K. et al. Clear cell ovarian adenocarcinoma. J. Sureg Oncol 1984;27:289—97.</mixed-citation><mixed-citation xml:lang="ru">Yoonessi M., Weldon D., Satchidand S.K. et al. Clear cell ovarian adenocarcinoma. J. Sureg Oncol 1984;27:289—97.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
